Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Master's Award: Canada Graduate Scholarships

McMaster University

$17,500.00

Investigation of the putative Type II Secretion System in Chlamydia pneumoniae and its relevance to persistance of infection.

EF 2009-10

Résumé
Chlamydia pneumoniae is an obligate intracellular pathogen associated with a variety of acute and chronic infections and diseases. It is responsible for 6-20% of community acquired pneumonia, exacerbation of chronic bronchitis and asthma and has more recently been distinguished as a risk factor for atherosclerosis, multiple sclerosis and Alzheimer's disease. The ubiquitous presence of this bacterium necessitates the creation of novel treatments specific for C. pneumoniae infections in an effort to alter the risk associated with its infection. The Type II Secretion System (T2SS) is a currently understudied area of research especially related to C. pneumoniae. It is primarily associated with secretion of enzymatic molecules required for degradation of the external milieu in order to provide nutrients to the replicating bacteria. This project would focus on extending the knowledge of the T2SS in C. pneumoniae via characterization of the secretion system including identification of currently unannotated protein components, determination of protein interactions and discovery of the secreted enzymes. The final goal of this project would be to identify various protein inhibitors that would eradicate the system's functionality. An important candidate to target with an inhibitor is the system's ATPase, which has been demonstrated in literature to have an essential interactions with several components of the system. These studies would contribute to the overall knowledge of C. pneumoniae and help elucidate clues to its strategy for persistence. Ideally, this information would also serve to identify areas to target with novel pharmaceutical therapies, such as peptide mimetics. These therapeutics are increasingly beneficial because they target subunit interactions, thereby reducing the potential for resistance acquisition. The eventual creation of a C. pneumoniae specific drug treatment would help alleviate its health burden on several common infections and diseases.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
199653
Name
Porfilio Elisa
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Infection and Immunity
Theme2
Biomedical
Prcname2
Canada Graduate Scholarships Master's Awards A
Projecttitle
Investigation of the putative Type II Secretion System in Chlamydia pneumoniae and its relevance to persistance of infection.
Programtype2
Studentship Programs
Orgnameinp2
McMaster University
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Chlamydia Pneumoniae; Persistence Of Infection; Type Ii Secretion System
Abstract
Chlamydia pneumoniae is an obligate intracellular pathogen associated with a variety of acute and chronic infections and diseases. It is responsible for 6-20% of community acquired pneumonia, exacerbation of chronic bronchitis and asthma and has more recently been distinguished as a risk factor for atherosclerosis, multiple sclerosis and Alzheimer's disease. The ubiquitous presence of this bacterium necessitates the creation of novel treatments specific for C. pneumoniae infections in an effort to alter the risk associated with its infection. The Type II Secretion System (T2SS) is a currently understudied area of research especially related to C. pneumoniae. It is primarily associated with secretion of enzymatic molecules required for degradation of the external milieu in order to provide nutrients to the replicating bacteria. This project would focus on extending the knowledge of the T2SS in C. pneumoniae via characterization of the secretion system including identification of currently unannotated protein components, determination of protein interactions and discovery of the secreted enzymes. The final goal of this project would be to identify various protein inhibitors that would eradicate the system's functionality. An important candidate to target with an inhibitor is the system's ATPase, which has been demonstrated in literature to have an essential interactions with several components of the system. These studies would contribute to the overall knowledge of C. pneumoniae and help elucidate clues to its strategy for persistence. Ideally, this information would also serve to identify areas to target with novel pharmaceutical therapies, such as peptide mimetics. These therapeutics are increasingly beneficial because they target subunit interactions, thereby reducing the potential for resistance acquisition. The eventual creation of a C. pneumoniae specific drug treatment would help alleviate its health burden on several common infections and diseases.
Competitiondate
201002
Approvedterm2
1 yr 0 mth
Pinamesdelim
Porfilio, Elisa
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~